Literature DB >> 2580100

Recombinant DNA approach for defining the primary structure of monoclonal antibody epitopes. The analysis of a conformation-specific antibody to myosin light chain 2.

F C Reinach, D A Fischman.   

Abstract

A monoclonal antibody (MF5), capable of recognizing a divalent cation-induced conformational change in myosin light chain 2 (LC2f), has been used to screen a cDNA library constructed in the expression vector lambda gt11. A clone has been isolated that contains the whole coding sequence of this myosin subunit. The light chain was synthesized as a fusion peptide linked to beta-galactosidase by ten amino acids encoded in the 5' untranslated region of its mRNA. Seven imperfect repeats were identified in the 3' untranslated region of the mRNA. The amino acids conferring specificity on the MF 5 epitope were established by first determining the nucleotide sequence of shorter subclones that expressed the epitope and then eliminating those amino acid residues shared by cardiac myosin LC2, which was unreactive with this antibody. The epitope, which becomes accessible to MF 5 upon removal of bound divalent cations, resides at the junction between the first alpha-helical domain and the metal binding site. Theoretically, this approach can be used to define the primary structure of most protein epitopes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580100     DOI: 10.1016/0022-2836(85)90229-3

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

1.  Probing myosin light chain 1 structure with monoclonal antibodies.

Authors:  B Cornillon; A M Cathiard; P Eldin; M Anoal; R Cardinaud; J P Liautard; M Le Cunff; D Mornet; F Pons; J Leger
Journal:  J Muscle Res Cell Motil       Date:  1992-06       Impact factor: 2.698

Review 2.  Myosin light chains and troponin C: structural and evolutionary relationships revealed by amino acid sequence comparisons.

Authors:  J H Collins
Journal:  J Muscle Res Cell Motil       Date:  1991-02       Impact factor: 2.698

3.  Expression of human beta-myosin heavy chain fragments in Escherichia coli; localization of actin interfaces on cardiac myosin.

Authors:  P Eldin; M Le Cunff; K W Diederich; T Jaenicke; B Cornillon; D Mornet; H P Vosberg; J J Léger
Journal:  J Muscle Res Cell Motil       Date:  1990-10       Impact factor: 2.698

4.  Screening an expression library with a ligand probe: isolation and sequence of a cDNA corresponding to a brain calmodulin-binding protein.

Authors:  J M Sikela; W E Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Localization of a factor VIII-inhibiting antibody epitope to a region between residues 338 and 362 of factor VIII heavy chain.

Authors:  J Ware; J R Toomey; D W Stafford
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Expression and DNA sequence analysis of a human embryonic skeletal muscle myosin heavy chain gene.

Authors:  I Karsch-Mizrachi; M Travis; H Blau; L A Leinwand
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

7.  Expression of cytoskeletal protein 4.1 during avian erythroid cellular maturation.

Authors:  N S Yew; H R Choi; J L Gallarda; J D Engel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

8.  Brush border myosin filament assembly and interaction with actin investigated with monoclonal antibodies.

Authors:  S Citi; J Kendrick-Jones
Journal:  J Muscle Res Cell Motil       Date:  1988-08       Impact factor: 2.698

9.  A point mutation in the regulatory light chain reduces the step size of skeletal muscle myosin.

Authors:  Jennifer J Sherwood; Guillermina S Waller; David M Warshaw; Susan Lowey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

10.  Regulation of scallop myosin by the regulatory light chain depends on a single glycine residue.

Authors:  A Jancso; A G Szent-Györgyi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.